Amplification of PAK1 and high PAK1 protein levels are found in several human cancers, including BC [7–9], and are linked to aggressive tumour types, chemotherapy resistance and poor prognosis [4, 10–14]. The gene discussed is PAK1; the disease is neoplasm.